Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients

Affiliation auteurs!!!! Error affiliation !!!!
TitreResults of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients
Type de publicationJournal Article
Year of Publication2018
AuteursBlanc J.-F, Khemissa F., Bronowicki J.-P, Monterymard C., Perarnau J.-M, Bourgeois V., Obled S., Abdelghani M.B, Mabile-Archambeaud I., Faroux R., Seitz J.-F, Locher C., Senellart H., Villing A.-L, Audemar F., Costentin C., Delplanque G., Manfredi S., Edeline J.
JournalJOURNAL OF HEPATOLOGY
Volume68
PaginationS195
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0168-8278
DOI10.1016/S0168-8278(18)30601-9